Leaflet BONFAL 20000UI film-coated tablets


Indicated for: calcium deficiency; osteoporosis

Route of administration: oral

Substance: cholecalciferol (vitamin)

ATC: A11CC05 (Alimentary tract and metabolism | Vitamin A and D, including combinations of the two | Vitamin D and analogues)

Cholecalciferol, also known as vitamin D3, is a form of vitamin D used for the prevention and treatment of vitamin D deficiency. It is essential for bone health as it aids in the absorption of calcium and phosphorus from food, preventing conditions such as rickets in children and osteomalacia or osteoporosis in adults.

Cholecalciferol is indicated in cases of vitamin D deficiency, for fracture prevention, and in the treatment of hypocalcemia associated with hypoparathyroidism. It is available in capsules, tablets, oral drops, or injectable solutions.

Side effects are rare but may include nausea, constipation, excessive thirst, or hypercalcemia (high calcium levels in the blood) in cases of overdose. It is contraindicated in patients with hypercalcemia, hypervitaminosis D, or severe renal impairment.

General data about BONFAL 20000UI

  • Substance: cholecalciferol
  • Date of last drug list: 01-09-2023
  • Commercial code: W69099002
  • Concentration: 20000UI
  • Pharmaceutical form: film-coated tablets
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

  • Manufacturer: SANECA PHARMACEUTICALS A.S. - REPUBLICA SLOVACA
  • Holder: WORWAG PHARMA GMBH & CO. KG - GERMANIA
  • Number: 14604/2022/02
  • Shelf life: 18 months

Pharmaceutical forms available for cholecalciferol

Concentrations available for cholecalciferol

  • 0.45mg/ml
  • 0.5mg/ml
  • 100.000UI/ml
  • 10000UI
  • 1000UI
  • 14400UI/ml
  • 18000UI/ml
  • 200000UI/ml
  • 20000UI
  • 20000UI/ml
  • 300.000UI/ml
  • 30000UI
  • 5000UI
  • 500UI
  • 7000UI